1291095-45-8 Usage
Uses
Used in Pharmaceutical Applications:
(2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-benzo[1,4]dioxin-6-ylmethyl)-4-ethyl-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol L-proline complex 1:1 is used as a pharmaceutical compound for its potential therapeutic properties. Its unique structure may offer novel mechanisms of action and applications in the treatment of various diseases and conditions.
Used in Biochemical Research:
In the field of biochemistry, this complex serves as a valuable research tool for studying the interactions between different biomolecules and the role of specific structural features in biological processes. Its unique composition allows for the investigation of molecular recognition, binding affinities, and potential enzymatic activities.
Used in Materials Science:
(2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-benzo[1,4]dioxin-6-ylmethyl)-4-ethyl-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol L-proline complex 1:1 is utilized in materials science for the development of new materials with specific properties. Its unique structure may contribute to the creation of advanced materials with applications in various industries, such as nanotechnology, polymer science, and biomaterials.
Check Digit Verification of cas no
The CAS Registry Mumber 1291095-45-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,1,0,9 and 5 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1291095-45:
(9*1)+(8*2)+(7*9)+(6*1)+(5*0)+(4*9)+(3*5)+(2*4)+(1*5)=158
158 % 10 = 8
So 1291095-45-8 is a valid CAS Registry Number.
1291095-45-8Relevant academic research and scientific papers
Glycoside Derivatives and Uses Thereof
-
, (2011/08/02)
This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.
